scispace - formally typeset
A

Agnieszka Berdowska

Researcher at Jan Długosz University

Publications -  28
Citations -  735

Agnieszka Berdowska is an academic researcher from Jan Długosz University. The author has contributed to research in topics: Steatosis & Insulin resistance. The author has an hindex of 12, co-authored 27 publications receiving 648 citations. Previous affiliations of Agnieszka Berdowska include University of Silesia in Katowice & Medical University of Silesia.

Papers
More filters
Journal Article

Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.

TL;DR: It is concluded that MS features of obesity are closely related to fasting and postprandial alterations of concentrations of PYY(3-36), CCK and ghrelin, suggesting that determination of gut hormones controlling food intake might be considered as a valuable tool to assess the progression of MS to comorbidities of obesity.
Journal ArticleDOI

Serum chemerin and vaspin in non-alcoholic fatty liver disease.

TL;DR: It is shown for the first time that chemerin and vaspin serum concentrations are altered in patients with NAFLD, and the analyzed adipokines appear to play a pivotal role in the pathogenesis of NAFLd, not only as regulators of insulin sensitivity, but also as mediators of the inflammatory process.
Journal ArticleDOI

Unique features of human cathelicidin LL-37.

TL;DR: This review intends to provide a brief overview of the expression, structure, properties and function of human cathelicidin LL‐37 which may be a therapeutic agent against a variety of bacterial and viral diseases, cancers, and hard‐to‐heal wounds.
Journal ArticleDOI

Chemerin, vaspin and insulin resistance in chronic hepatitis C

TL;DR: A complex interaction between the analysed adipokines and pathogenesis of inflammatory process in CHC is supported and the role of chemerin and vaspin in pathogenic of inflammatory response should be further investigated.
Journal Article

Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery.

TL;DR: The study showed a positive association between visfatin and the fibrosis stage in NAFLD, suggesting a potential role of this adipokine in the pathogenesis and progression ofNAFLD.